See the DrugPatentWatch profile for vascepa

Based on the information available, there is no definitive answer to what the average insurance savings for Vascepa (icosapent ethyl) is. This is because insurance savings for prescription medications can vary greatly depending on a number of factors, including the specific insurance plan, the patient's deductible and co-pay, and the availability of generic alternatives.

However, it is mentioned on DrugPatentWatch.com that Vascepa is a patented medication, and its patent is set to expire in 2029 [1]. This means that there is currently no generic version of Vascepa available on the market, which could potentially impact the insurance savings for this medication.

Additionally, Vascepa is used to treat very high levels of triglycerides (a type of fat) in the blood, and it is often used in combination with a statin medication to lower cholesterol levels [2]. The cost of Vascepa can vary, but it is generally considered to be a specialty medication, which can be more expensive than other types of prescription drugs [3].

In summary, while there is no specific information available on the average insurance savings for Vascepa, it is a patented medication with no generic alternatives currently available, which could impact the potential insurance savings. Patients are encouraged to speak with their healthcare provider and insurance provider to understand the potential costs and insurance coverage for Vascepa.

Sources:
[1] <https://www.drugpatentwatch.com/drugs/vascepa>
[2] <https://medlineplus.gov/druginfo/meds/a614022.html>
[3] <https://www.goodrx.com/vascepa>